-+ 0.00%
-+ 0.00%
-+ 0.00%
An Aehr Test Systems Vice President Sells 1,000 Shares as the Stock Soars. Here's a Deeper Look at the Transaction.
Share
Listen to the news

Key Points

  • The transaction involved 1,000 shares liquidated at $108.49 per share for a total value of $108,490 on August 10, 2026.

  • The disposition represents a 4% reduction in direct holdings and 3% of the insider's total equity position.

  • Remaining holdings are distributed between 22,547 shares held directly and 5,177 shares held indirectly by a trust.

Alistair N. Sporck, Vice President of the Contactor Business Unit at Aehr Test Systems, Inc. (NASDAQ:AEHR), sold 1,000 shares of common stock on August 10, 2026, according to an SEC Form 4 filing.

Transaction summary

Metric Value
Transaction value $108,490
Shares sold (directly held) 1,000
Post-transaction shares (directly held) 22,547
Post-transaction shares (indirectly held) 5,177
Post-transaction value ~$2.9 million

Transaction value based on SEC Form 4 weighted average sale price ($108.49); post-transaction value based on August 10, 2026 market close ($106.20).

Key questions

  • How does this sale align with the insider's total equity exposure?
    The transaction was a modest liquidity event, as Alistair N. Sporck retains 97% of their total equity stake, including both direct ownership and shares held via trust.
  • Are there specific conditions attached to the remaining shares?
    Direct holdings reported in this filing include shares subject to unvested restricted stock units, ensuring continued long-term alignment with the company's performance.
  • How does the transaction price compare to recent market levels?
    The execution at $108.49 per share occurred at a slight premium to the $106.20 market close on the day of the transaction.

Company Overview

Metric Value
Share Price (as of market close 2026-08-10) $106.20
Market Capitalization $3.5 billion
Revenue (TTM) $50.9 million
Net Income (TTM) -$7.1 million

Company Snapshot

  • Aehr Test Systems designs and manufactures advanced burn-in and test systems for integrated circuits, including logic, optical, and memory devices, with principal product families comprising the ABTS and FOX-P systems alongside specialized components such as the FOX WaferPak Aligner and FOX DiePak Carrier.
  • The company generates revenue through the sale of proprietary test and burn-in equipment to semiconductor manufacturers and foundries, supplemented by recurring revenue from service, maintenance, and consumable components associated with its installed equipment base.
  • Aehr Test Systems serves global semiconductor manufacturers, foundries, and integrated device manufacturers requiring advanced thermal and electrical testing solutions for high-reliability integrated circuit validation and production.

Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a specialized provider of mission-critical test and burn-in systems serving the global semiconductor industry. The company maintains a focused operational footprint with 138 employees while generating $50.9 million in trailing twelve-month revenue, reflecting its position as a niche supplier of high-value equipment to semiconductor manufacturers.

With a market cap of $3.5 billion and significant recent appreciation, Aehr Test Systems represents a capital-efficient business model dependent on technological differentiation and customer concentration within the semiconductor equipment sector.

What this transaction means for investors

VP Alistair Sporck’s Aug. 10 sale of Aehr Test Systems stock occurred after shares attained a 484% one-year total return. It appears Sporck was capitalizing on the price increase to capture gains.

That said, the disposition only comprised a modest 3% of Sporck’s total equity position. Post-transaction holdings of over 27,000 suggest the insider maintains continued alignment with shareholder interests.

Aehr Test Systems is up thanks to an outstanding earnings report for its fiscal fourth quarter ended May 29. Revenue rose to $18.8 million, up from $14.1 million in the prior year. This demonstrates the growing customer demand the company is seeing for its semiconductor testing capabilities as a result of the rapidly expanding artificial intelligence sector.

Its growing revenue enabled the company to achieve fiscal Q4 net income of $1.4 million, an impressive reversal from the prior year’s net loss of $2.9 million. For its 2027 fiscal year, Aehr forecasted approximately 160% to 200% year-over-year sales growth. The astounding increase in net income and the next fiscal year’s revenue also contributed to the stock’s rise.

Robert Izquierdo has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending